0.38Open0.33Pre Close36 Volume3.35K Open Interest5.00Strike Price758.00Turnover962.99%IV1.17%PremiumJul 19, 2024Expiry Date0.14Intrinsic Value100Multiplier-1DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.6301Delta0.7533Gamma18.69Leverage Ratio-2.5899Theta0.0000Rho11.78Eff Leverage0.0002Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet